Top Markets
#1 ADO Protocol ADO Protocol +328.82%
#2 GoPlus Security GoPlus Security +54.02%
#3 Starpower Starpower +44.49%
#4 Tutorial Tutorial +34.66%
#5 Verus Coin Verus Coin +33.62%
#6 Nockchain Nockchain +32.34%
#7 Chainflip Chainflip +28.11%
#8 The Black Bull The Black Bull +25.66%
#9 GAIB AID GAIB AID +24.67%
#10 peaq peaq +17.79%
Coin of the day
ADO Protocol ADO Protocol
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Pharmena S.a. Pharmena S.a.

Pharmena S.a.

PHR
Classifica tra le azioni #32515
Pharmena S.A. engages in the sale of dietary supplements in Poland and... Pharmena S.A. engages in the sale of dietary supplements in Poland and internationally. It also develops 1-MNA (PHR-701 program), a medical device for use in difficult-to-heal wounds. In addition, the company is involved in research and development of therapeutic applications of 1 MNA as an anti-inflammatory and anti-fibrotic drug; and research and development at pulmonary fibrosis, respiratory tract infections, including viral infections, COVID-19, inflammatory diseases, metabolic diseases and other therapeutic applications. Pharmena S.A. was founded in 2002 and is based in Lódz, Poland. Pharmena S.A. operates as a subsidiary of Pelion S.A.
Prezzo delle azioni
$0.88679187
Capitalizzazione di mercato
$9.88M
Variazione (1 giorno)
-1.56%
Variazione (1 anno)
-7.31%
Paese
PL
Scambia Pharmena S.a. (PHR)

Categoria

Healthcare
EPS per Pharmena S.a. (PHR)
EPS al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Pharmena S.a., l’EPS attuale della società (TTM) è 0. Alla fine del 2026, la società aveva un EPS di 0 uguale a rispetto a quello del 2026, che era di 0.
Storico EPS per Pharmena S.a. da 2026 a 2026
EPS alla fine di ogni anno
Anno EPS Cambia
Non abbastanza dati per le date fornite.
EPS per aziende simili o concorrenti
Azienda EPS Differenza di EPS Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $13.70 -
BE